
Molecule: BLINATUMOMAB
ChEMBL ID: CHEMBL1742992
Mechanism of Action: CROSS-LINKING AGENT
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2014

Molecule: TAPLITUMOMAB PAPTOX
ChEMBL ID: CHEMBL2107890
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: COLTUXIMAB RAVTANSINE
ChEMBL ID: CHEMBL2109286
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: ONCOLYSIN B
ChEMBL ID: CHEMBL2109308
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody

Molecule: INEBILIZUMAB
ChEMBL ID: CHEMBL2109334
Mechanism of Action: BINDING AGENT
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2020

Molecule: DENINTUZUMAB MAFODOTIN
ChEMBL ID: CHEMBL3545371
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: DENINTUZUMAB
ChEMBL ID: CHEMBL3544992
Mechanism of Action: BINDING AGENT
Max Phase: -1.0
Molecule Type: Antibody

Molecule: MDX-1342
ChEMBL ID: CHEMBL2109337
Mechanism of Action: BINDING AGENT
Max Phase: 1.0
Molecule Type: Antibody

Molecule: AMG-729
ChEMBL ID: CHEMBL2109338
Mechanism of Action: BINDING AGENT
Max Phase: 1.0
Molecule Type: Antibody

Molecule: AXICABTAGENE CILOLEUCEL
ChEMBL ID: CHEMBL3989989
Mechanism of Action: BINDING AGENT
Max Phase: 4.0
Molecule Type: Gene
First Approval: 2018

Molecule: TISAGENLECLEUCEL
ChEMBL ID: CHEMBL3301574
Mechanism of Action: BINDING AGENT
Max Phase: 4.0
Molecule Type: Cell
First Approval: 2018

Molecule: TAFASITAMAB
ChEMBL ID: CHEMBL4298047
Mechanism of Action: BINDING AGENT
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2020

Molecule: BREXUCABTAGENE AUTOLEUCEL
ChEMBL ID: CHEMBL4594618
Mechanism of Action: BINDING AGENT
Max Phase: 4.0
Molecule Type: Gene
First Approval: 2020

Molecule: LONCASTUXIMAB TESIRINE
ChEMBL ID: CHEMBL4297778
Mechanism of Action: BINDING AGENT
Max Phase: 4.0
Molecule Type: Antibody drug conjugate
First Approval: 2021

Molecule: LISOCABTAGENE MARALEUCEL
ChEMBL ID: CHEMBL4297236
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Gene

Molecule: OBEXELIMAB
ChEMBL ID: CHEMBL4298134
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody
